About The Medical Condition EN-1639A
Find the definition of the medical term EN-1639A. EN-1639A defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
EN-1639A
| EN-1639A Medical Condition |
|---|
What's The Definition Of The Medical Condition EN-1639A?
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Occupational Dermatitides ‐ A recurrent contact dermatitis caused by substances found in…
- Methyl Yellow ‐ A reagent used mainly to induce experimental liver cancer. According…
- Capillary Resistance, Hematologic ‐ The lack of resistance, or susceptibility, of capillaries to…
- Blood Platelet Transfusion ‐ The transfer of blood platelets from a donor to a recipient or…
- Cranial Epidural Abscess ‐ Circumscribed collections of suppurative material occurring in…
- Molluscacides ‐ Agents destructive to snails and other…
- Aminotransferase, GABA-alpha-Ketoglutarate ‐ An enzyme that converts brain gamma-aminobutyric acid (GAMMA-AMINOBUTYRIC…
- Deficiency, Smooth Pursuit ‐ Disorders that feature impairment of eye movements as a primary…
- Habituation, Psychophysiologic ‐ The disappearance of responsiveness to accustomed stimulation.…
- ICI-46,474 ‐ One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS, it is agonist…